Aprotinin: safe and effective only with the full-dose regimen.
Publication
, Journal Article
Smith, PK; Muhlbaier, LH
Published in: Ann Thorac Surg
December 1996
Duke Scholars
Published In
Ann Thorac Surg
DOI
ISSN
0003-4975
Publication Date
December 1996
Volume
62
Issue
6
Start / End Page
1575 / 1577
Location
Netherlands
Related Subject Headings
- Respiratory System
- Myocardial Infarction
- Humans
- Hemostatics
- Coronary Artery Bypass
- Blood Loss, Surgical
- Aprotinin
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Smith, P. K., & Muhlbaier, L. H. (1996). Aprotinin: safe and effective only with the full-dose regimen. Ann Thorac Surg, 62(6), 1575–1577. https://doi.org/10.1016/s0003-4975(96)00958-7
Smith, P. K., and L. H. Muhlbaier. “Aprotinin: safe and effective only with the full-dose regimen.” Ann Thorac Surg 62, no. 6 (December 1996): 1575–77. https://doi.org/10.1016/s0003-4975(96)00958-7.
Smith PK, Muhlbaier LH. Aprotinin: safe and effective only with the full-dose regimen. Ann Thorac Surg. 1996 Dec;62(6):1575–7.
Smith, P. K., and L. H. Muhlbaier. “Aprotinin: safe and effective only with the full-dose regimen.” Ann Thorac Surg, vol. 62, no. 6, Dec. 1996, pp. 1575–77. Pubmed, doi:10.1016/s0003-4975(96)00958-7.
Smith PK, Muhlbaier LH. Aprotinin: safe and effective only with the full-dose regimen. Ann Thorac Surg. 1996 Dec;62(6):1575–1577.
Published In
Ann Thorac Surg
DOI
ISSN
0003-4975
Publication Date
December 1996
Volume
62
Issue
6
Start / End Page
1575 / 1577
Location
Netherlands
Related Subject Headings
- Respiratory System
- Myocardial Infarction
- Humans
- Hemostatics
- Coronary Artery Bypass
- Blood Loss, Surgical
- Aprotinin
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences